Further studies have shown that TGFβ/Smad pathway can be activated by platelet-secreted TGFβ1 and NF-κB pathway can be triggered by direct contact between tumor cells and platelets, and the latter can enhance the TGFβ1 transcriptional response of tumor cells. This evidence concerns the gene NFKB1 and neoplasm.